PMC:7299399 / 5267-5794 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":92,"end":98},"obj":"Body_part"},{"id":"T14","span":{"begin":388,"end":393},"obj":"Body_part"},{"id":"T15","span":{"begin":483,"end":488},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma84116"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":102,"end":110},"obj":"Disease"},{"id":"T33","span":{"begin":224,"end":244},"obj":"Disease"},{"id":"T34","span":{"begin":253,"end":261},"obj":"Disease"},{"id":"T35","span":{"begin":304,"end":312},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005087"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T50","span":{"begin":113,"end":116},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T51","span":{"begin":150,"end":151},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T52","span":{"begin":185,"end":190},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T53","span":{"begin":323,"end":324},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T54","span":{"begin":343,"end":348},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T55","span":{"begin":382,"end":393},"obj":"http://purl.obolibrary.org/obo/CLO_0053065"},{"id":"T56","span":{"begin":483,"end":488},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":68,"end":76},"obj":"Chemical"},{"id":"T17","span":{"begin":395,"end":406},"obj":"Chemical"},{"id":"T18","span":{"begin":425,"end":427},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T7","span":{"begin":468,"end":474},"obj":"http://purl.obolibrary.org/obo/GO_0098739"},{"id":"T8","span":{"begin":468,"end":474},"obj":"http://purl.obolibrary.org/obo/GO_0098657"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-sentences","denotations":[{"id":"T27","span":{"begin":88,"end":497},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"LitCovid-PubTator","denotations":[{"id":"111","span":{"begin":429,"end":433},"obj":"Gene"},{"id":"112","span":{"begin":102,"end":112},"obj":"Species"},{"id":"113","span":{"begin":202,"end":215},"obj":"Species"},{"id":"114","span":{"begin":253,"end":261},"obj":"Species"},{"id":"115","span":{"begin":304,"end":312},"obj":"Species"},{"id":"116","span":{"begin":382,"end":387},"obj":"Species"},{"id":"117","span":{"begin":224,"end":244},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"tao:has_database_id","subj":"111","obj":"Gene:59272"},{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"Tax:2697049"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"Tax:11118"},{"id":"A114","pred":"tao:has_database_id","subj":"114","obj":"Tax:694009"},{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"Tax:694009"},{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Tax:9606"},{"id":"A117","pred":"tao:has_database_id","subj":"117","obj":"MESH:D012140"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}

{"project":"2_test","denotations":[{"id":"32519842-32015507-158454","span":{"begin":137,"end":139},"obj":"32015507"},{"id":"32519842-32257431-158455","span":{"begin":262,"end":264},"obj":"32257431"},{"id":"32519842-32015507-158456","span":{"begin":489,"end":491},"obj":"32015507"},{"id":"32519842-32333836-158457","span":{"begin":492,"end":494},"obj":"32333836"},{"id":"32519842-32142651-158458","span":{"begin":495,"end":497},"obj":"32142651"}],"text":"D-19, harnessing all of the tools and technologies modern molecular medicine can offer.\nThe genome of SARS-CoV-2 has been fully sequenced19 and shows a high degree of similarity in key genes with other coronaviruses causing respiratory diseases such as SARS-CoV.20 Based on knowledge gathered during the SARS-CoV epidemic, a key target of the virus includes the surface receptor in human cells, angiotensin-converting enzyme II (ACE2), which is required for efficient uptake in host cells.19,21−23\nThe C-terminal domain (i.e., "}